Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Citing this Article

Right click to copy or hit: ctrl+c (cmd+c on mac)

Published on 01.02.17 in Vol 3, No 1 (2017): Jan-Mar

This paper is in the following e-collection/theme issue:

Works citing "Using Social Listening Data to Monitor Misuse and Nonmedical Use of Bupropion: A Content Analysis"

According to Crossref, the following articles are citing this article (DOI 10.2196/publichealth.6174):

(note that this is only a small subset of citations)

  1. Sarker A, DeRoos A, Perrone J. Mining social media for prescription medication abuse monitoring: a review and proposal for a data-centric framework. Journal of the American Medical Informatics Association 2020;27(2):315
    CrossRef
  2. Smart R, Kase CA, Taylor EA, Lumsden S, Smith SR, Stein BD. Strengths and weaknesses of existing data sources to support research to address the opioids crisis. Preventive Medicine Reports 2020;17:101015
    CrossRef
  3. O'Connor K, Sarker A, Perrone J, Gonzalez Hernandez G. Promoting Reproducible Research for Characterizing Nonmedical Use of Medications Through Data Annotation: Description of a Twitter Corpus and Guidelines. Journal of Medical Internet Research 2020;22(2):e15861
    CrossRef
  4. Wang D, Su J, Yu H. Feature Extraction and Analysis of Natural Language Processing for Deep Learning English Language. IEEE Access 2020;8:46335
    CrossRef
  5. Audeh B, Bellet F, Beyens M, Lillo-Le Louët A, Bousquet C. Use of Social Media for Pharmacovigilance Activities: Key Findings and Recommendations from the Vigi4Med Project. Drug Safety 2020;
    CrossRef
  6. Audeh B, Calvier F, Bellet F, Beyens M, Pariente A, Lillo-Le Louet A, Bousquet C. Pharmacology and social media: Potentials and biases of web forums for drug mention analysis—case study of France. Health Informatics Journal 2019;:146045821986512
    CrossRef
  7. van Stekelenborg J, Ellenius J, Maskell S, Bergvall T, Caster O, Dasgupta N, Dietrich J, Gama S, Lewis D, Newbould V, Brosch S, Pierce CE, Powell G, Ptaszyńska-Neophytou A, Wiśniewski AFZ, Tregunno P, Norén GN, Pirmohamed M. Recommendations for the Use of Social Media in Pharmacovigilance: Lessons from IMI WEB-RADR. Drug Safety 2019;42(12):1393
    CrossRef
  8. Iliou T, Casta P, Lequeux J, Pochard L, Frauger E, Spadari M, Micallef J. Venlafaxine Abuse in a Patient With a History of Methylphenidate Abuse. Journal of Clinical Psychopharmacology 2019;39(2):172
    CrossRef
  9. Meacham MC, Roh S, Chang JS, Ramo DE. Frequently asked questions about dabbing concentrates in online cannabis community discussion forums. International Journal of Drug Policy 2019;74:11
    CrossRef
  10. Keller MS, Mosadeghi S, Cohen ER, Kwan J, Spiegel BMR. Reproductive Health and Medication Concerns for Patients With Inflammatory Bowel Disease: Thematic and Quantitative Analysis Using Social Listening. Journal of Medical Internet Research 2018;20(6):e206
    CrossRef
  11. Chen X, Faviez C, Schuck S, Lillo-Le-Louët A, Texier N, Dahamna B, Huot C, Foulquié P, Pereira S, Leroux V, Karapetiantz P, Guenegou-Arnoux A, Katsahian S, Bousquet C, Burgun A. Mining Patients' Narratives in Social Media for Pharmacovigilance: Adverse Effects and Misuse of Methylphenidate. Frontiers in Pharmacology 2018;9
    CrossRef
  12. Taylor J, Pagliari C. Mining social media data: How are research sponsors and researchers addressing the ethical challenges?. Research Ethics 2018;14(2):1
    CrossRef
  13. Schifano F, Chiappini S. Is There a Potential of Misuse for Venlafaxine and Bupropion?. Frontiers in Pharmacology 2018;9
    CrossRef
  14. Schifano F, Chiappini S, Corkery J, Guirguis A. Abuse of Prescription Drugs in the Context of Novel Psychoactive Substances (NPS): A Systematic Review. Brain Sciences 2018;8(4):73
    CrossRef
  15. Caster O, Dietrich J, Kürzinger M, Lerch M, Maskell S, Norén GN, Tcherny-Lessenot S, Vroman B, Wisniewski A, van Stekelenborg J. Assessment of the Utility of Social Media for Broad-Ranging Statistical Signal Detection in Pharmacovigilance: Results from the WEB-RADR Project. Drug Safety 2018;41(12):1355
    CrossRef
  16. Comfort S, Perera S, Hudson Z, Dorrell D, Meireis S, Nagarajan M, Ramakrishnan C, Fine J. Sorting Through the Safety Data Haystack: Using Machine Learning to Identify Individual Case Safety Reports in Social-Digital Media. Drug Safety 2018;41(6):579
    CrossRef
  17. Bousquet C, Dahamna B, Guillemin-Lanne S, Darmoni SJ, Faviez C, Huot C, Katsahian S, Leroux V, Pereira S, Richard C, Schück S, Souvignet J, Lillo-Le Louët A, Texier N. The Adverse Drug Reactions from Patient Reports in Social Media Project: Five Major Challenges to Overcome to Operationalize Analysis and Efficiently Support Pharmacovigilance Process. JMIR Research Protocols 2017;6(9):e179
    CrossRef
  18. Kim SJ, Marsch LA, Hancock JT, Das AK. Scaling Up Research on Drug Abuse and Addiction Through Social Media Big Data. Journal of Medical Internet Research 2017;19(10):e353
    CrossRef
  19. Daniulaityte R, Lamy FR, Barratt M, Nahhas RW, Martins SS, Boyer EW, Sheth A, Carlson RG. Characterizing marijuana concentrate users: A web-based survey. Drug and Alcohol Dependence 2017;178:399
    CrossRef

According to Crossref, the following books are citing this article (DOI 10.2196/publichealth.6174)

:
  1. Dasgupta N, Winokur C, Pierce C. Communicating about Risks and Safe Use of Medicines. 2020. Chapter 11:307
    CrossRef